This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: A Study to Explore the Role of IDH1 (R132) Mutation on Imatinib
Toxicity and Effect of ABCG2/OCT1 Expression on N-Desmethyl Imatinib
Plasma Level in Egyptian Chronic Myeloid Leukemia Patients, Drug Research, January 2023, Thieme Publishing Group,
DOI: 10.1055/a-1924-7746.
You can read the full text:
The following have contributed to this page
